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ABSTRACT: Methods for isobaric tagging of peptides, iTRAQ or
TMT, are commonly used platforms in mass spectrometry based
quantitative proteomics. These two methods are very often used to
quantitate proteins in complex samples, e.g., serum/plasma or CSF
supporting biomarker discovery studies. The success of these studies
depends on multiple factors, including the accuracy of ratios of
reporter ions reﬂecting quantitative changes of proteins. Because
reporter ions are generated during peptide fragmentation, the dif-
ferences of chemical structure of iTRAQ balance groups may have an
eﬀect on how eﬃciently these groups are fragmented and thus how
diﬀerences in protein expression will be measured. Because 4-plex
and 8-plex iTRAQ reagents do have diﬀerent structures of balanced
groups, it has been postulated that indeed diﬀerences in protein
identiﬁcation and quantitation exist between these two reagents. In
this study we controlled the ratios of tagged samples and compared quantitation of proteins using 4-plex versus 8-plex
reagents in the context of a highly complex sample of human plasma using ABSciex 4800 MALDI-TOF/TOF mass
spectrometer and ProteinPilot 4.0 software. We observed that 8-plex tagging provides more consistent ratios than 4-plex
without compromising protein identiﬁcation, thus allowing investigation of eight experimental conditions in one analytical
experiment.
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■ INTRODUCTION
One major goal of proteomic proﬁling is an accurate quan-
titation of proteins in samples with high complexity and
high dynamic range of protein concentrations, such as body
ﬂuids (serum, plasma, CSF, etc). Because high conﬁdence
peptide/protein identiﬁcation and at the same time high
conﬁdence quantitation is a highly challenging task, multi-
ple analytical approaches have been developed based on
separation of proteins in-gel (2DE DIGE) and/or gel-free
platform utilizing various methods of metabolic or chemical
labeling.
1 Each quantitative platform, including isobaric tags
for relative and absolute quantitation (iTRAQ), has strengths
and limitations that have been experimentally compared.
2
iTRAQwasdevelopedintheearly2000stobeappliedforthe
multidimensional protein identiﬁcation technology (MudPIT)
approach in which proteins are fragmented with trypsin or
other proteolytic enzyme and subsequently chemically labeled
with isobaric tags. This platform became a central technology
in modern proteomics research; it is being widely used in all
areasofresearchwithgreatutility.
3−8Asmuchasthisapproach
seems to be straightforward, many aspects of this proteomic
platform add sources of variability, and these limit the con-
ﬁdence in the output of protein identiﬁcation and quantita-
tion. The variability is introduced in multiple steps of sample
preparation, eﬃciency of chemical tagging, performance of
instrumentation, and method of acquisition used, as well as
software (algorithms) and thresholds deﬁned for database
searches. Importantly, 4-plex and 8-plex tags provide overlapping
mass of reporter ions; however, their balance groups are diﬀerent,
which has been postulated to have an impact on yield of
fragmentation in collision induced dissociation (CID) leading to
bias in quantitation.
Nevertheless, iTRAQ-based quantitation is an attractive
method in global proteomic quantitation. First, it can be used
after processing of any sample, e.g., cell lysates and proteins
obtained from organelles, and as such is not limited to only
those systems that can accommodate incorporation of stable
isotopes during cell culture. Second, iTRAQ accommodates
multiplexing up to 8 conditions/samples. Third, software for
proteinidentiﬁcationandquantitationisfairlywelldeveloped
and tested in numerous experimental settings.
Recently Pichler and co-workers found that peptide labeling
with 4-plex tags yields higher identiﬁcation rates compared to
8-plex tags.
9 This conclusion is of concern since experimental
designs using 8-plex allow a much greater level and ease of
comparison. For example, a study of one control and seven
experimental conditions can be performed in one 8-plex
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( r u n n i n gt h ec o n t r o la n du pt ot h r e ee x p e r i m e n t a ls a m p l e si n
each). This increases the amount of control sample needed,
labor and supplies, and chromatography and mass spectrom-
etry time and likely introduces a source of variability.
The goal of this study was to compare experimental ratios of
highlycomplexsamplestaggedwith4-plexversus8-plexreagents
in controlled ratios. We used ProteinPilot 4.0 software for data
analysis, which is associated with the ABSciex 4800 MALDI-
TOF/TOF mass spectrometer.
■ MATERIALS AND METHODS
Materials
Ammonium phosphate, α-cyano-4-hydroxycinammic acid
(CHCA),andtriﬂuoroaceticacid(TFA)werefromSigmaAldrich
(St. Louis, MO, USA). HPLC grade water and acetonitrile
(MeCN;ACN)werefromFisherScientiﬁc(Pittsburgh,PA,USA).
Sample Processing
Human plasma samples were shipped on dry ice from University
of California−San Diego (UCSD) to University of Nebraska
Medical Center (UNMC) and on arrival remained frozen. HIV
was inactivated in all samples by addition of 10 μL of freshly
prepared 10% Triton X-100 and 50 μL of a cocktail of protease
inhibitors (Sigma-Aldrich St. Louis, MO) per 1 mL of sample.
After 30 min samples were aliquoted, and those unused were
storedat−80°C.A250μLportionfromeachsamplewasﬁltered
using a 0.2 μm spin ﬁlter and immunodepleted using an IgY14
column (Sigma-Aldrich) to remove the following proteins:
albumin, α1-antitrypsin, IgM, haptoglobin, ﬁbrinogen, α1-acid
glycoprotein, apolipoprotein A-I and A-III, apolipoprotein B,
IgG, IgA, transferrin, α2-macroglobulin, and complement C3.
Flow-through fractions containing unbound proteins were
concentratedusingaVivaspin15R(Sartorius,Aubagne,France).
Protein concentration was determined using a NanoDrop
spectrophotometer (Thermo Scientiﬁc, San Jose, CA). A total
of 400 μg of proteins was pooled, and then aliquots of 50 μgo f
proteins were used in order to perform the iTRAQ labeling.
Trypsin Digest and Sample Processing
A5 0μg sample of proteins was precipitated with ethanol, by
adding 10 vol of cold ethanol (200 proof) to each sample,
incubating for 3 h at −20 °C, and centrifuging at 13,000g for
15 min at 4 °C. Proteins pellets were washed with 1 mL of
70% ethanol and dried in a SpeedVac (Thermo Scientiﬁc).
Subsequent solutions were provided by iTRAQ reagent kits
(Applied Biosystem, Carlsbad, CA).
Dried proteins were solubilized with dissolution solution, and
proteins were denaturated with 1 μL of denaturant reagent.
Proteinreductionwithreducingreagentwasperformedfor1hat
60°C.According tothe manufacturer protocol, samples used for
iTRAQ 4-plex were alkylated with 84 mM iodoacetamide for
30 min at room temperature, whereas for iTRAQ 8-plex we used
the cysteine blocking solution from the iTRAQ kit for 10 min at
room temperature.
Samples were split and trypsin digested in parallel. Trypsin
from ABI was reconstituted at 1 μg/μL with Milli-Q water, and
10 μg of trypsin was added to each sample. Digestion was
performed for 16 h at 37 °C. After digestion, peptides were
labeled with iTRAQ label reagent (ABI); 4-plex labeling was
performed for 1 h at room temperature, and after the incubation
the reaction was quenched with 100 μL of mQ water for 30 min
at room temperature. The 8-plex labeling was performed for 2 h
at room temperature. Labeled peptides were combined in one
tube; we mixed a known quantity of peptides from each tag (see
experimental design, Figure 1). Finally, pooled peptides were
dried with the SpeedVac.
Sampleswerecleanedupusingmixedcationexchange(MCX)
column (Water Corp., Milford, MA). Labeled peptides were
solubilized with 1 mL of 0.1% formic acid, passed through the
column, and then the column was washed with 5% methanol,
0.1% formic acid solution, and then with HPLC grade methanol.
Peptides were eluted with 1.4% NH4OH in methanol.
Samples were dried and reconstituted in 1.44 mL of 0.1%
formic acid. Then, 360 μL of reconstituted sample was
supplemented with1.44mLofOFFGELsolution.Next, samples
werefractionatedonthebasisoftheirisoelectricpoint(pI)using
3100 OFFGEL Fractionator (Agilent, Inc. Santa Clara, CA).
OFFGELstripswererehydratedfor15minatroomtemperature
with 40 μL of OFFGEL solution. Peptide samples were loaded
onto gel strips, splitting them equally between all 12 wells.
Separation was performed for 20,000 V·h.
Collected fractions were cleaned with C-18 spin columns,
according to the manufacturer’s protocol. Brieﬂy, fractions were
adjusted to 5% acetonitrile (ACN) and 0.5% triﬂuoracetic acid
(TFA) and passed through activated columns. Columns were
washed twice with a 5% ACN, 0.5% TFA solution, and peptides
were eluted with a 70% ACN, 0.1% TFA solution. Peptides were
ﬁnally dried and stored at −80 °C until further use.
Oﬀ Line LC−MS/MS Analysis
Subsequent fractionation of OFFGEL fractions was performed
oﬀ-line using Tempo LC system with automatic high density
spotting onto MALDI target plates. Peptides were solubilized in
12 μL of 0.1% TFA, and 10 μL of samples were loaded onto a
ProteoCol C18 trap cartridge (Michrom Biosources, Auburn,
CA) and washed for 20 min at 9 μL/min. Gradient of separation
was obtained using a ratio between two buﬀers: water/ACN/
TFA (98:2:0.1) (Buﬀer A) and water/ACN/TFA (2:98:0.1)
(Buﬀer B). To perform the separation, the subsequent gradient
wasappliedbyalteringBuﬀerBpercentage:time0−5min,5%to
15%; 5−52 min, 15% to 35%; 52−54 min, 35% to 80%; 54−
64 min, 80%; 64−65 min, 80% to 5%; and 65−72, min 5%.
Peptide elution was monitored with a UV cell at 214 nm
absorbance. After the UV cell, eluted peptides were mixed with a
matrix solution (1.2 mg/mL in 75% ACN and 0.1% TFA
solution) at a ﬂow rate 1 μL/min using a Harvard Apparatus
syringe pump. Fractions were spotted every 30 s, and the voltage
applied to the plate during spotting was 2.8 kV.
Spotted fractions were submitted for data acquisition on a
4800 MALDI-TOF/TOF mass spectrometer (ABI). MS spectra
were acquired from 800 to 3000 m/z, for a total of 1000 laser
shotsbyanNd:YAGlaseroperatingat355nmand200Hz.Laser
intensityremainsﬁxedforalltheanalyses.MS/MSanalyseswere
performed using 2 kV collision energy with air as CID gas.
Metastable ions were suppressed, for a total of 1000 laser shots.
Protein identiﬁcation and quantiﬁcation were performed with
ProteinPilot 4.0 software using Paragon algorithm. The search
parameters were as follows: iTRAQ 4-plex (peptide labeled),
carbamidomethylation of cysteine, NCBI database (created on
December 2011) restricted to Homo sapiens, iTRAQ 8-plex
(peptide labeled), methylthioalkylation of cysteine, NCBI
database (created on December 2011) restricted to Homo
sapiens, for iTRAQ 4-plex and 8-plex, respectively.
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Our experimental design (Figure 1) used one large pool of
human plasma immunodepleted of the 14 most abundant
proteins. Regardless of how much of the resulting peptides was
used to create ﬁnal ratios, we always used 50 μg during the
reaction for iTRAQ labeling. This approach eliminated potential
variability that might be associated with eﬃciency of chemical
labeling when ratios to tag and peptides are not uniform. After
tagging, peptides were mixed in 1:2:3:4 ratios. In Experiment 1
we used 114, 115, 116, and 117 tags from 4-plex and from 8-plex
kits and combined the following amount of labeled peptides
(separately for the 4-plex and 8-plex) to achieve a 1:2:3:4 ratio
Figure 1. Layout of experimental design. Samples used in all three experiments (400, 600 and 650 μg) were taken from the same larger pool of
immunodepleted plasma samples (see Materials and Methods for details of immunodepletion). In all experiments regardless how much tagged peptides
were used for analyses, 50 μg of peptide digest was always used for iTRAQ tagging to eliminate any eﬀect of the tag to peptide ratio between experiments.
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(117). In Experiment 2 we repeated these conditions and added
a third sample in which the 113, 118, 119, and 121 tags from the
8-plex kit were used and peptides again mixed in a 1:2:3:4 ratio.
However, in Experiment 3 we compared labeling of 114, 115,
116,and117tagsfromthe8-plexkittolabelingwithalleighttags
fromthesame8-plexkit.Relativetotheﬁrsttwoexperiments,we
scrambled tag assignment to the amount of peptides used, which
allowed us to limit another potential bias (tag eﬀect). In
Experiment3we alsoadded50μgofnon-labeledpeptidesto the
sample labeled with four tags to make up for the diﬀerence
between amounts of peptides between those labeled with all
eight tags. In all three experiments we used the same conditions
forfractionation basedonisoelectric pointandsubsequently RP-
HPLCinTempoLCplatespotter.Alldatawereprocessedbythe
same version of ProteinPilot with the same version of database.
InFigure2weshowtheresultsderivedfromExperiment1.All
ratios were calculated relative to peptides tagged with 117
reporter ion. Ideally we should observe ratios of 0.25 (114:117),
0.5 (115:117), and 0.75 (116:117). Here we have made two
observations. First, as conﬁdence of protein identiﬁcation
decreases (plotted on the x-axis), the ratios for individual
proteins (plotted on the y-axis) become more dispersed and the
groups start to overlap. Second, when we used tags from the
4-plex kit, ratios of 114:117 showed lower than expected values,
whereas when we used tags from the 8-plex kit the ratio of
114:117 was as expected (0.25). The two other ratios were very
similar for both kits, and all were slightly higher than expected.
In Figure 3 we present a comprehensive comparison of ratios
derived from all three experiments as a box-plot analysis. As
shown in panel A, comparison of the ratios from Experiment 2
shows a greater dispersion of data when tags from the 4-plex kit
were used. Comparison of the box (containing the values from
25% to 75% of the ratios) reveals that the tags from the 8-plex
that have reporter masses similar to those of the 4-plex have a
tighter distribution than those from the 4-plex. In panel B we
present analysis of the spread of ratios for tags 115, 116, and 117
from the 8-plex kit relative to the 114 tag when labeled samples
weremixedwithanequalamountofnon-labeledpeptides.Inthis
experiment measured ratios indicated that the presence of non-
labeled peptides skewed results toward lower than expected
values, which would have been 0.75 (115/114), 0.50 (116/114),
and 0.25 (117/114), respectively. Dispersion of ratios was
highestfor115/114andlowestfor117/114.InpanelCweshow
comparison of ratios from the second part of Experiment 3 in
whichweusedalltagsfromthe8-plexkit;however,sampleswere
mixed in 1:1, 1:2, 1:3, and 1:4 ratios and all were calculated as
relative to the 113 tag. In this data set experimental ratios
matched expected values for the following tags: 115/113 was
0.75, 116/113 was 0.5. Ratios for tags 117/113 and 121/113
were comparable to each other; however, both were below the
0.2markwhileweexpectedthemtobeatthe0.25mark.Ratiosof
118/113, 119/113, and 114/113 were skewed to lower values
quite substantially in some instances. Besides the fact that higher
ratios had a larger spread of values in the top and bottom
quartiles,therewasnoobviouspatternofsystematicskewofdata
in either the top or bottom quartiles across all comparisons.
Whilemanuallyanalyzingratiosforindividualpeptideslabeled
with the diﬀerent tags, we have found three predominant
patterns of ratios regardless of whether the 4-plex or 8-plex assay
was used (Figure 4B). Among them, linear dependence (pattern 1,
Figure 4B) is the most desirable and expected and is repre-
sentative of more than 80% of all patterns found (Figure 4A).
More than 90% of peptides (Figure 4A) are included when these
three patterns are combined. Although more than 80% of
peptides showed linear ratios, we were interested in what impact
the non-linear patterns have on the overall quantitative ratio
of a protein and whether these non-linear patterns may skew
quantitation. To investigate such possibility we selected two
proteins: serpin peptidase inhibitor, clade G, member 1 pre-
cursor and hemopexin precursor. The peptides that contributed
to the overall ratios of these two proteins contained a mixture of
the three predominant peptide ratios as presented in Figure 4.
ResultsofthisanalysisarepresentedinFigure5andindicatethat
despite having a mixture of all three patterns of peptide ratios,
protein quantitation still shows linearity.
Figure2.CorrelationbetweenconﬁdenceofproteinidentiﬁcationandratiosofiTRAQreporterions.DatapresentedinthisﬁgurearefromExperiment
1in Figure 1. Proteins were plotted by decreasing value of conﬁdence of identiﬁcation (x axis) and ratiosthat were calculated as relative to 117 reporter
ion (y axis). (A) Plot for 114, 115, and 116 m/z reporter ions from iTRAQ 4-plex kit. (B) Ratios for the same m/z set ofreporter ions from iTRAQ 8-plex kit.
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that for samples labeled with iTRAQ 8-plex, the number of
peptide-spectrum matches and unique peptides was more than
70% lower and the number of protein groups more than 60%
lower, as compared to iTRAQ 4-plex.
9 We identiﬁed 72 proteins
with 99% and 98 with 66% conﬁdence, respectively, using the
4-plex iTRAQ kit, and 64 and 90 proteins for the respective
thresholds when we used the 8-plex iTRAQ kit. When we used a
50% conﬁdence cutoﬀ level, we found that samples labeled with
8-plex showed a decrease in identiﬁcations of only 13% at the
peptideleveland19%attheproteinlevel,andwhencomparedto
4-plex these diﬀerences were not statistically signiﬁcant. It is
important to note that Pichler et al. performed their quantitation
and identiﬁcation using a LTQ Orbitrap and CID-HCD hybrid
method and searches were performed using Mascot and
Proteome Discoverer. We used MALDI 4800 with ProteinPilot
4.0 with Paragon Algorithm, which has an impact on the number
of proteins identiﬁed.
■ DISCUSSION
iTRAQ, as with any other analytical tool, is under continuous
scrutiny by scientists looking for ways of most accurate mea-
surements in quantitative proteomics.
10−12 Because global
proﬁling with quantitation is a multistep experiment, the ﬁnal
output may depend on wide range of factors ultimately con-
tributing to skewed oreven falsepositive results. Onesolutionto
prevent contribution of errors originating from iTRAQ data
analysesistighteningthresholds;however,thisapproachmustbe
used with caution because it may easily lead to loss of important
information. Therefore, iTRAQ is being constantly evaluated
and each study emphasizes diﬀerent aspects of this approach.
Gan and co-workers assessed the reliability of iTRAQ from
perspective of diﬀerent types of replicate analyses and took into
account technical, experimental, and biological variations.
2
Mahoney and co-workers reported that measured variability
was a function of mean abundance, fold changes were biased
toward the null, and variance of a fold change was a function of
protein mass and abundance.
10 Ow and co-workers
13 evaluated
the quantitative dynamic range of iTRAQ quantitation in high-
andlow-complexitysamples.Althoughtheirstudyhassimilarities
in experimental design, there are also important diﬀerences,
including the use of non-mammalian samples to create a high
complexity background, spiking in strategy to measure ratios,
strong cation exchange (SCX) separation in ﬁrst dimension, and
aqTOFmassspectrometryplatform.Inasubsequentpaper
14the
authors used a similar strategy of spiking in known proteins to
evaluate accuracy and precision of iTRAQ based quantitation
and proposed spiking as a method to address accuracy and
variance-stabilizing normalization to address the issue of preci-
sion.
14Inanotherstudyevaluatingaccuracyofquantitationusing
iTRAQ ratios Thingholm and co-workers used whole HeLa
cell lysate as a model sample and focused on phosphopeptides
after enrichment on a TiO2 column.
15 The authors used ESI as
ionization mode and a LTQ XL Orbitrap as mass spectro-
metry platform. They reported correlation between reduc-
tions in identiﬁcation eﬃciency with the size of the isobaric tag.
Taking all these studies together, we have gained knowledge
into understanding the iTRAQ platform; however, our study
presented here oﬀers insight from a diﬀerent perspective. Here
we perform a calculated experiment using immunodepleted
human plasma, a body ﬂuid that is highly complex and has a high
dynamic range of protein concentration. Another way our study
diﬀerssigniﬁcantlyisthatweuseaMALDI-TOF/TOFplatform,
followed by ProteinPilot 4.0 data analysis, both of which are
oﬀered from and supported by ABSciex, the manufacturers of
iTRAQ. Other groups focused on software and mathematical
models for iTRAQ data analyses and comparing algorithms
across many platforms.
16−19 Despite the collective eﬀort, many
outstanding questions related to accuracy and sources of vari-
ability in iTRAQ technique
20 remain to be addressed, and more
systematic studies with direct comparisons across mass spectro-
metry platforms, complexity of samples, and sample preparation
methodsareneededtofullyunderstandbiasresultingfromiTRAQ
quantitation.
We were intrigued by the report of Pichler and co-workers
showing that peptide labeling with 4-plex tags yields higher
Figure 3. Box-plot of the ratios comparing eﬀect of tags from iTRAQ 4-
plex and 8 plex kits. Data presented are from Experiment 2 in panel A
andfromExperiment3inpanelsBandC.(A).Ratioswerecalculatedas
relativetothehighestamountofpeptidestaggedwith117for4-plexand
8-plexand121for8-plexonly.Therefore, theﬁrstthreebox-plots repre-
sent a 1:4 ratio (expected value 0.25), the second three box-plots
represent a 1:2 ratio (expected value 0.5), and the third set of box-plots
represents a 3:4 ratio (expected value 0.75). (B). Box-plot analysis
of ratios from tagging peptides with 114, 115, 116, and 117 tags from
8-plex kit and mixed with an equal amount (50 μg) of non-labeled
peptides. Ratios were calculated relative to 114 iTRAQ tag. (C). Box-
plot analysis of ratios of peptides tagged with all 8 tags from 8-plex kit.
The amount of peptide digest was the same (100 μg) as in panel B.
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9 The authors used a
LTQ Orbitrap mass spectrometer, CID-HCD hybrid method,
and Proteome Discoverer Software (Thermo Scientiﬁc). The
authors attributed the diﬀerences in yields to diﬀerences in
chemicalstructuresofbalancegroupsandconcludedthatbalance
groups used in 8-plex tags are less susceptible to fragmenta-
tion. However on the basis of our previous experience we found
not only that were the diﬀerences in peptide and protein
identiﬁcations low but that the 8-plex tags resulted in increased
conﬁdence of quantitation with limited impact on protein
identiﬁcation. Taking this together we decided to test this eﬀect
using a systematic experimental approach to examine this as well
as the accuracy of ratios obtained from intensities of the reporter
ions with simpliﬁed experimental design to remove as much bias
aspossible.Weintentionallychosehumanplasmabecauseofour
past work on biomarker discovery in body ﬂuids (CSF, serum,
and plasmaanalyses) andbecause it constitutes a highly complex
mixture of proteins with high dynamic range of relative
concentrations.
21−28 Plasma/serum and CSF have been used
in many biomarker discovery studies, including using iTRAQ
Figure 4. Observed patterns of peptides’ ratios. Ideally, all peptides labeled with iTRAQ tags should show quantitative and linear ratios representing
controlledmixingofproteinsamples.Inreality,wehavefoundsevennon-linearornochangepatternsrepresentinglessthan20%ofthetotalnumberof
peptides(A).ExpectedlinearpatternisshowninpanelB,andthetwomostpredominantnon-linearpatternsareshowninpanelsCandD,respectively.
When combined, these three patterns represent more than 90% of peptides. Data are based on Experiment 1 (Figure.1).
Figure 5. Impact of non-linear peptide ratio on quantitative protein ratios. Two proteins, serpin peptidase inhibitor, clade G, member 1 precursor and
hemopexinprecursor,wereselectedforthiscomparison.Selectionwasbasedonthefactthatinbothcasesoverallproteinratioswerecalculatedbasedon
peptidesrepresentingamixtureofpatterns1,2,and3showninFigure4.Inbothinstances,Serpinpeptidaseinhibitor,cladeG,member1precursor(A)
and hemopexin precursor (B) proteins showed overall linearity of ratios despite a mixture of linear and non-linear peptide ratios.
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population of clinical samples was disappointing, leaving ques-
tions about thesources ofsuchdisconnect unanswered. We used
one large sample of immunodepleted plasma securing identical
material for all experiments. Biological variability, although very
important, was not an objective of our study, and pooling multi-
ple samples averaged levels of proteins in the mix. Importantly,
we used a MALDI-TOF/TOF 4800 mass spectrometer and
ProteinPilot software with Paragon Algorithm, which are
diﬀerent than those used by Pichler and co-workers.
9
We have found that 8-plex tags performed with higher
quantitation accuracy than the same (by m/z of reporter ions)
tags from 4-plex reagent, providing experimental ratios closer to
theoretical ratios without dramatically aﬀecting peptide or
protein identiﬁcation. Also, when conﬁdence of protein iden-
tiﬁcation decreases, the spread of ratios increases in both
instances, however, to a lesser extent when 8-plex tags are used
(Figure 3A). Therefore we conclude that more consistent ratios
wouldbedue tomore complete CIDfragmentation oftags using
MALDI mass spectrometry. Box-plot analysis of ratios from
subsequent experiments showed that spread of ratios is much
tighter in two middle quartiles when 8-plex tags are used.
Additionally, labeling peptides with 8-plex tags yielded more
peptideswithlineardependenceofcalculatediTRAQratios,thus
better reﬂecting the ratio of controlled mixing.
Skewing of the measured ratios in the 1:1 mixture of tagged
and nontagged peptides was an unexpected eﬀect considering
that the same amount of peptides tagged with 8-plex yielded
ratios close to their theoretical values. In the mixture of tagged
and nontagged peptides, for each peptide there were two
diﬀerent precursor ions that yielded identical or very similar
fragmentationspectra.Allspectracouldcontributetoconﬁdence
of protein identiﬁcation; however, only half of the spectra
contributed to quantitation. If peptide fragmentation used for
protein identiﬁcation and fragmentation of tags used for
quantitation are processed by algorithm as separate events and
results are merged at the ﬁnal step, such eﬀect should not be
observed. On the other hand, if quantitation and identiﬁcation is
considered by algorithm as one event, 50% of spectra with null
quantitation may induce a systematic skew in the calculation of
ratios. Therefore, completeness of tagging may have a quite
profound eﬀect on quantitative output even if such incomplete
tagging is proportional to all of the peptides in the sample. Also
results from Experiment 1 may also suggest that ratio can be
aﬀected by either low level of precursor ion and thus more frag-
ment ions were under background level and/or poor frag-
mentation during CID. We observed in other iTRAQ experi-
ments examples in which the intensity of reporter ions was
clearly above background providing good quantitation, but
CID fragmentation of the tagged peptide was so poor that
identiﬁcationwascalculated withconﬁdencebelow 1%(data not
shown).
Summarizing, we provide here experimental evidence that
under our experimental conditions, 8-plex tagging is advanta-
geous over 4-plex tagging in two aspects. First, 8-plex tagging
provides more consistent ratios without compromising on
protein identiﬁcation. Second, the 8-plex system of tagging
allows investigation of eight experimental conditions in one
analytical experiment. A question that remains to be addressed
is whether, during iTRAQ data acquisition, the peptide and
reporter ion fragmentation that leads to identiﬁcation and quan-
titation,respectively,shouldbeconsideredastwoseparateevents
or dependent on each other. This would need to be addressed
formally in subsequent experiments.
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